Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen QIAscout for Single-Cell Isolation

Qiagen has launched QIAscout, an instrument for isolation of of viable single cells from samples for downstream applications. It uses the company's technology including a high-density array with 12,000 microrafts that can be used to isolate and recover individual cells from a cell suspension. QIAscout works with standard inverted microscopes to reliably select and release isolated single cells. The instrument is the size of a handheld mobile device. In addition, the company has entered an exclusive commercialization partnership with Zeiss Microscopy to market the QIAscout as a convenient add-on feature to all of its inverted microscopes.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.